Overall survival of PEGylated pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC) Meeting Abstract


Authors: Hecht, J. R.; Naing, A.; Falchook, G. S.; Patel, M. R.; Infante, J. R.; Aljumaily, R.; Wong, D. J. L.; Autio, K. A.; Wainberg, Z. A.; Javle, M. M.; Bendell, J. C.; Pant, S.; Hung, A.; Van Vlasselaer, P.; Leveque, J.; Oft, M.; Papadopoulos, K. P.
Abstract Title: Overall survival of PEGylated pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 231s
Language: English
ACCESSION: WOS:000442916002016
DOI: 10.1200/JCO.2018.36.15_suppl.4119
PROVIDER: wos
Notes: Meeting Abstract: 4119 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    119 Autio